Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1937]
News [3134]
Articles [127]
Editorials [3]
Conferences [120]
elearning [13]
Benefits of azacitidine for treatment of myelodysplastic syndromes
Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital...
Benefits of azacitidine for treatment of myelodysplastic syndromes ( Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France )
6 May 2009
Epigenetics of myelodysplastic syndromes
Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital...
Epigenetics of myelodysplastic syndromes ( Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France )
6 May 2009
Innovation in the treatment of myelodysplastic syndromes
Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital...
Innovation in the treatment of myelodysplastic syndromes ( Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France )
6 May 2009
Myelodysplastic syndromes (MDS)
Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital...
Myelodysplastic syndromes (MDS) ( Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France )
6 May 2009
AACR 2009: Frequent JAK Mutations in Pediatric Acute Lymphoblastic Leukemia...
Dr Charles Mullighan - Department of Pathology, St Jude Children's Research...
AACR 2009: Frequent JAK Mutations in Pediatric Acute Lymphoblastic Leukemia (ALL) with Poor Outcome: A New Therapeutic Target in Resistant Disease ( Dr Charles Mullighan - Department of Pathology, St Jude Children's Research Hospital )
30 Apr 2009
AACR 2009: Membrane microfilter device for capture and characterisation of...
Anthony Williams - Keck School of Medicine, University of Southern California
AACR 2009: Membrane microfilter device for capture and characterisation of circulating tumour cells ( Anthony Williams - Keck School of Medicine, University of Southern California )
30 Apr 2009
AACR 2009: Genetic susceptibility for chronic lymphocytic leukaemia
Professor Susan Slager - Division of Biostatistics, Mayo Clinic College of...
AACR 2009: Genetic susceptibility for chronic lymphocytic leukaemia ( Professor Susan Slager - Division of Biostatistics, Mayo Clinic College of Medicine, USA )
30 Apr 2009
Bacteria as agents to initiate potent anti-tumour activity
Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of...
Bacteria as agents to initiate potent anti-tumour activity ( Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of Oncology, Milan )
31 Mar 2009
Managing cardiotoxicity while treating cancer
Dr Carlo Cipolla - Director of the Cardioncology Division, European Institute...
Managing cardiotoxicity while treating cancer ( Dr Carlo Cipolla - Director of the Cardioncology Division, European Institute of Oncology, Milan )
18 Mar 2009
Azacitidine for Myelodysplastic Syndrome
Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease...
Azacitidine for Myelodysplastic Syndrome ( Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York )
19 Feb 2009
Effects of Myelodysplastic Syndrome
Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease...
Effects of Myelodysplastic Syndrome ( Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York )
19 Feb 2009
How azacitidine works
Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease...
How azacitidine works ( Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York )
19 Feb 2009

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation